Neurovations, a leading clinical research and consulting company in the fields of pain management and neuroscience, is pleased to announce Renée Bell as its director of clinical research. Ms. Bell brings 25 years of experience to Neurovations, with many successes in expanding research operations, particularly in the pharmaceutical industry.
Ms. Bell will be responsible for managing the clinical research operation at Neurovations. She will work alongside clinical education staff to develop mutual synergies with more than 25 client companies, including early stage and industry leading firms.
“Renée is an excellent addition to our team,” said Neurovations Founder and President Eric Grigsby, MD, MBA. “We see a great opportunity in the clinical research arena for a research company like ours that provides high quality, rapid enrollment, clean data collection and reporting, and understands the cycle for advancing patient treatment care. Neurovations has built a solid reputation on these qualities. Renée brings the operational and strategic experience to help us expand our research sites and collaborate with our business partners to deliver new innovative patient treatments.”
Renée’s professional experience includes working as Director of Clinical Operations for Medici Global, Director of Clinical Research for Neurocare Center for Research.
“I’m delighted to join the Neurovations clinical research team led by Dr. Eric Grigsby,” Bell said. “It’s a dynamic organization with an excellent reputation for quality. I look forward to working with Dr. Grigsby and his staff to expand Neurovations by increasing the number of research sites, new drug trials, and device treatments as well as more investigator-initiated trials.”
